192 related articles for article (PubMed ID: 15601869)
1. v-Myb mediates cooperation of a cell-specific enhancer with the mim-1 promoter.
Chayka O; Kintscher J; Braas D; Klempnauer KH
Mol Cell Biol; 2005 Jan; 25(1):499-511. PubMed ID: 15601869
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Myb-responsive enhancer of the chicken C/EBPbeta gene.
Kintscher J; Yamkamon V; Braas D; Klempnauer KH
Oncogene; 2004 Jul; 23(34):5807-14. PubMed ID: 15195136
[TBL] [Abstract][Full Text] [Related]
3. C/EBPbeta induces chromatin opening at a cell-type-specific enhancer.
Plachetka A; Chayka O; Wilczek C; Melnik S; Bonifer C; Klempnauer KH
Mol Cell Biol; 2008 Mar; 28(6):2102-12. PubMed ID: 18195047
[TBL] [Abstract][Full Text] [Related]
4. Myb-induced chromatin remodeling at a dual enhancer/promoter element involves non-coding rna transcription and is disrupted by oncogenic mutations of v-myb.
Wilczek C; Chayka O; Plachetka A; Klempnauer KH
J Biol Chem; 2009 Dec; 284(51):35314-24. PubMed ID: 19841477
[TBL] [Abstract][Full Text] [Related]
5. Synergistic activation of the chicken mim-1 gene by v-myb and C/EBP transcription factors.
Burk O; Mink S; Ringwald M; Klempnauer KH
EMBO J; 1993 May; 12(5):2027-38. PubMed ID: 8491193
[TBL] [Abstract][Full Text] [Related]
6. Interaction of C/EBPbeta and v-Myb is required for synergistic activation of the mim-1 gene.
Mink S; Kerber U; Klempnauer KH
Mol Cell Biol; 1996 Apr; 16(4):1316-25. PubMed ID: 8657104
[TBL] [Abstract][Full Text] [Related]
7. The v-Myb oncoprotein activates C/EBPbeta expression by stimulating an autoregulatory loop at the C/EBPbeta promoter.
Mink S; Jaswal S; Burk O; Klempnauer KH
Biochim Biophys Acta; 1999 Oct; 1447(2-3):175-84. PubMed ID: 10542314
[TBL] [Abstract][Full Text] [Related]
8. A dual activation mechanism for Myb-responsive genes in myelomonocytic cells.
Yamkamon V; Ivanova O; Braas D; Chayka O; Patmasiriwat P; Klempnauer KH
Blood Cells Mol Dis; 2008; 40(2):219-26. PubMed ID: 17950008
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic point mutations in the Myb DNA-binding domain alter the DNA-binding properties of Myb at a physiological target gene.
Ivanova O; Braas D; Klempnauer KH
Nucleic Acids Res; 2007; 35(21):7237-47. PubMed ID: 17959653
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the DNA-binding and transcriptional activation domains of v-Myb cooperate in transformation.
Dini PW; Eltman JT; Lipsick JS
J Virol; 1995 Apr; 69(4):2515-24. PubMed ID: 7884901
[TBL] [Abstract][Full Text] [Related]
11. tom-1, a novel v-Myb target gene expressed in AMV- and E26-transformed myelomonocytic cells.
Burk O; Worpenberg S; Haenig B; Klempnauer KH
EMBO J; 1997 Mar; 16(6):1371-80. PubMed ID: 9135152
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of the Myb-inducible promoter of the chicken adenosine receptor 2B gene.
Kattmann D; Klempnauer KH
Oncogene; 2002 Jul; 21(30):4663-72. PubMed ID: 12096342
[TBL] [Abstract][Full Text] [Related]
13. Interaction and functional collaboration of p300 and C/EBPbeta.
Mink S; Haenig B; Klempnauer KH
Mol Cell Biol; 1997 Nov; 17(11):6609-17. PubMed ID: 9343424
[TBL] [Abstract][Full Text] [Related]
14. The glioma-amplified sequence 41 gene (GAS41) is a direct Myb target gene.
Braas D; Gundelach H; Klempnauer KH
Nucleic Acids Res; 2004; 32(16):4750-7. PubMed ID: 15356292
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of c-Myb-C/EBP beta cooperation from separated sites on a promoter.
Tahirov TH; Sato K; Ichikawa-Iwata E; Sasaki M; Inoue-Bungo T; Shiina M; Kimura K; Takata S; Fujikawa A; Morii H; Kumasaka T; Yamamoto M; Ishii S; Ogata K
Cell; 2002 Jan; 108(1):57-70. PubMed ID: 11792321
[TBL] [Abstract][Full Text] [Related]
16. Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types.
Ness SA; Kowenz-Leutz E; Casini T; Graf T; Leutz A
Genes Dev; 1993 May; 7(5):749-59. PubMed ID: 7684005
[TBL] [Abstract][Full Text] [Related]
17. Cloning of the novel human myeloid-cell-specific C/EBP-epsilon transcription factor.
Chumakov AM; Grillier I; Chumakova E; Chih D; Slater J; Koeffler HP
Mol Cell Biol; 1997 Mar; 17(3):1375-86. PubMed ID: 9032264
[TBL] [Abstract][Full Text] [Related]
18. The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene.
Ness SA; Marknell A; Graf T
Cell; 1989 Dec; 59(6):1115-25. PubMed ID: 2688896
[TBL] [Abstract][Full Text] [Related]
19. Endogenous CCAAT/enhancer binding protein beta and p300 are both regulated by growth hormone to mediate transcriptional activation.
Cui TX; Piwien-Pilipuk G; Huo JS; Kaplani J; Kwok R; Schwartz J
Mol Endocrinol; 2005 Aug; 19(8):2175-86. PubMed ID: 15860545
[TBL] [Abstract][Full Text] [Related]
20. Tumorigenic N-terminal deletions of c-Myb modulate DNA binding, transactivation, and cooperativity with C/EBP.
Oelgeschläger M; Kowenz-Leutz E; Schreek S; Leutz A; Lüscher B
Oncogene; 2001 Nov; 20(50):7420-4. PubMed ID: 11704872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
